Citation: Bh. Schmidt et R. Heinig, THE PHARMACOLOGICAL BASIS FOR METRIFONATES FAVORABLE TOLERABILITY IN THE TREATMENT OF ALZHEIMERS-DISEASE, Dementia and geriatric cognitive disorders, 9, 1998, pp. 15-19
Citation: Vc. Hinz et al., EFFECTS OF SUBCHRONIC ADMINISTRATION OF METRIFONATE ON CHOLINERGIC NEUROTRANSMISSION IN RATS, Neurochemical research, 23(7), 1998, pp. 931-938
Citation: L. Spowart et al., METRIFONATE AFFECTS THE PEAK INTERVAL PERFORMANCE IN THE RAT, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 121-121
Citation: Bh. Schmidt, EFFECTS OF LONG-TERM ACETYLCHOLINESTERASE INHIBITION ON THE FUNCTIONALITY OF BRAIN CHOLINERGIC NEUROTRANSMISSION IN-VIVO, Journal of neurochemistry, 71, 1998, pp. 1-1
Citation: M. Riekkinen et al., SUBCHRONIC TREATMENT INCREASES THE DURATION OF THE COGNITIVE ENHANCEMENT INDUCED BY METRIFONATE, European journal of pharmacology, 338(2), 1997, pp. 105-110
Citation: Fj. Vanderstaay et al., EFFECTS OF METRIFONATE ON ESCAPE AND AVOIDANCE-LEARNING IN YOUNG AND AGED RATS, Behavioural pharmacology, 7(1), 1996, pp. 56-64
Citation: Vc. Hinz et al., METRIFONATE INDUCES CHOLINESTERASE INHIBITION EXCLUSIVELY VIA SLOW-RELEASE OF DICHLORVOS, Neurochemical research, 21(3), 1996, pp. 331-337
Citation: V. Hinz et al., METRIFONATE AND DICHLORVOS - EFFECTS OF A SINGLE ORAL-ADMINISTRATION ON CHOLINESTERASE ACTIVITY IN RAT-BRAIN AND BLOOD, Neurochemical research, 21(3), 1996, pp. 339-345
Authors:
HINZ VC
BLOKLAND A
VANDERSTAAY FJ
GEBERT I
SCHUURMAN T
SCHMIDT BH
Citation: Vc. Hinz et al., RECEPTOR INTERACTION PROFILE AND CNS GENERAL PHARMACOLOGY OF METRIFONATE AND ITS TRANSFORMATION PRODUCT DICHLORVOS IN RODENTS, Drug development research, 38(1), 1996, pp. 31-42
Authors:
KOPPEN A
KLEIN J
SCHMIDT BH
VANDERSTAAY FJ
LOFFELHOLZ K
Citation: A. Koppen et al., EFFECTS OF NICOTINAMIDE ON CENTRAL CHOLINERGIC TRANSMISSION AND ON SPATIAL-LEARNING IN RATS, Pharmacology, biochemistry and behavior, 53(4), 1996, pp. 783-790
Citation: Fj. Vanderstaay et al., EFFECTS OF METRIFONATE, ITS TRANSFORMATION PRODUCT DICHLORVOS, AND OTHER ORGANOPHOSPHORUS AND REFERENCE CHOLINESTERASE-INHIBITORS ON MORRISWATER ESCAPE BEHAVIOR IN YOUNG-ADULT RATS, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 697-708
Citation: G. Hofner et Bh. Schmidt, SPECIES-DIFFERENCES IN [H-3] LINOPIRDINE (DUP-996) BINDING TO BRAIN MEMBRANES, European journal of pharmacology, 298(3), 1996, pp. 307-312
Citation: A. Blokland et al., EFFECTS OF METRIFONATE AND TACRINE IN THE SPATIAL MORRIS TASK AND MODIFIED IRWIN TEST - EVALUATION OF THE EFFICACY SAFETY PROFILE IN RATS/, Drug development research, 36(4), 1995, pp. 166-179
Authors:
HEGEMANN L
HATZELMANN A
GREWIG S
SCHMIDT BH
Citation: L. Hegemann et al., POTENT ANTAGONISM OF CALMODULIN ACTIVITY IN-VITRO, BUT LACK OF ANTIPROLIFERATIVE EFFECTS ON KERATINOCYTES BY THE NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR MK-886, British journal of dermatology, 133(1), 1995, pp. 41-47
Citation: Bh. Schmidt et F. Chaouloff, THE ABILITY OF IPSAPIRONE TO STIMULATE NEUROENDOCRINE RESPONSES IS PRESERVED AFTER ITS SUBCHRONIC ADMINISTRATION TO RATS, Neuropsychopharmacology, 9(2), 1993, pp. 190000150-190000150
Citation: Bh. Schmidt et F. Chaouloff, CHRONIC TREATMENT WITH AN ANXIOLYTIC DOSE OF THE 5-HT(1A) AGONIST IPSAPIRONE DOES NOT ALTER IPSAPIRONE ACUTE NEUROENDOCRINE EFFECTS, Psychoneuroendocrinology, 18(7), 1993, pp. 457-466